Contact
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals to Complete Phase 2 Trial of Brilacidin for Oral Mucositis in Cancer Patients
TO:
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals to Complete Phase 2 Trial of Brilacidin for Oral Mucositis in Cancer Patients
TO: